相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic Review of Cuff and Pouch Cancer in Patients with Ileal Pelvic Pouch for Ulcerative Colitis
Francesco Selvaggi et al.
INFLAMMATORY BOWEL DISEASES (2014)
Ubiquitin-conjugating enzyme E2C: A potential cancer biomarker
Chanlu Xie et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond
Umberto Malapelle et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (II)
Laurence Egan et al.
JOURNAL OF CROHNS & COLITIS (2014)
Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)
Shaji Sebastian et al.
JOURNAL OF CROHNS & COLITIS (2014)
Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer
Woo-Jeong Jeong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Resistance to EGFR blockade in colorectal cancer: liquid biopsies and latent subclones
David J. Konieczkowski et al.
CELL RESEARCH (2013)
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status
Pierlorenzo Pallante et al.
EUROPEAN JOURNAL OF CANCER (2013)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Jean-Yves Douillard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Role of targeted agents in metastatic colorectal cancer
Hans Prenen et al.
TARGETED ONCOLOGY (2013)
Expression of UbcH10 in pancreatic ductal adenocarcinoma and its correlation with prognosis
Ze-Kun Zhao et al.
TUMOR BIOLOGY (2013)
Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets
D. C. Gilbert et al.
BRITISH JOURNAL OF CANCER (2012)
UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer
Liming Zhao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Sanger sequencing in routine KRAS testing: a review of 1720 cases from a pathologist's perspective
Umberto Malapelle et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker
Zhonglin Hao et al.
TUMOR BIOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
mTOR Complex 2 Targets Akt for Proteasomal Degradation via Phosphorylation at the Hydrophobic Motif
You-Tong Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Processive ubiquitin chain formation by the anaphase-promoting complex
Hermann-Josef Meyer et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Wendy De Roock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro
Lei Jiang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Association of clinicopathological features with UbcH10 expression in colorectal cancer
Shimin Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation
Janine H. van Ree et al.
JOURNAL OF CELL BIOLOGY (2010)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock et al.
LANCET ONCOLOGY (2010)
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines
Silvia La Monica et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer
Takeo Fujita et al.
BMC CANCER (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex
Lingyan Jin et al.
CELL (2008)
The unique N terminus of the UbcH10 E2 enzyme controls the threshold for APC activation and enhances checkpoint regulation of the APC
Matthew K. Summers et al.
MOLECULAR CELL (2008)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
A mathematical approach to study combined effects of toxicants in vitro:: Evaluation of the Bliss independence criterion and the Loewe additivity model
Matteo Goldoni et al.
TOXICOLOGY IN VITRO (2007)
The processivity of multiubiquitination by the APC determines the order of substrate degradation
M Rape et al.
CELL (2006)
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas
P Pallante et al.
BRITISH JOURNAL OF CANCER (2005)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin
KW Wagner et al.
ONCOGENE (2004)
ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions
PP Roux et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)
Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
